XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Beginning of period (in shares) at Oct. 01, 2022   27,679,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   210,000        
Treasury shares purchased (in shares)   (391,000)        
End of period (in shares) at Jul. 01, 2023   27,498,000        
Beginning of period at Oct. 01, 2022 $ 1,095,731 $ 541 $ 652,467 $ (1,093,483) $ 1,572,234 $ (36,028)
Exercise of stock options and vesting of other share-based awards   2        
Share-based compensation expense     15,539      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (12,331)      
Treasury shares purchased       (37,431)    
Net income 98,833       98,833  
Other comprehensive (loss) income 24,019         24,019
End of period at Jul. 01, 2023 1,184,362 $ 543 655,675 (1,130,914) 1,671,067 (12,009)
Beginning of period (in shares) at Apr. 01, 2023   27,647,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   1,000        
Treasury shares purchased (in shares)   (150,000)        
End of period (in shares) at Jul. 01, 2023   27,498,000        
Beginning of period at Apr. 01, 2023 1,182,382 $ 543 651,667 (1,117,360) 1,655,268 (7,736)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     4,057      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (49)      
Treasury shares purchased       (13,554)    
Net income 15,799       15,799  
Other comprehensive (loss) income (4,273)         (4,273)
End of period at Jul. 01, 2023 $ 1,184,362 $ 543 655,675 (1,130,914) 1,671,067 (12,009)
Beginning of period (in shares) at Sep. 30, 2023 27,466,000 27,466,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   190,000        
Treasury shares purchased (in shares)   (371,000)        
End of period (in shares) at Jun. 29, 2024 27,285,000 27,285,000        
Beginning of period at Sep. 30, 2023 $ 1,214,382 $ 543 661,270 (1,134,429) 1,711,328 (24,330)
Exercise of stock options and vesting of other share-based awards   2        
Share-based compensation expense     19,759      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (10,830)      
Treasury shares purchased       (36,145)    
Net income 70,594       70,594  
Other comprehensive (loss) income 8,598         8,598
End of period at Jun. 29, 2024 $ 1,266,360 $ 545 670,199 (1,170,574) 1,781,922 (15,732)
Beginning of period (in shares) at Mar. 30, 2024   27,470,000        
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)   0        
Treasury shares purchased (in shares)   (185,000)        
End of period (in shares) at Jun. 29, 2024 27,285,000 27,285,000        
Beginning of period at Mar. 30, 2024 $ 1,259,762 $ 545 663,130 (1,151,997) 1,756,782 (8,698)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     7,074      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (5)      
Treasury shares purchased       (18,577)    
Net income 25,140       25,140  
Other comprehensive (loss) income (7,034)         (7,034)
End of period at Jun. 29, 2024 $ 1,266,360 $ 545 $ 670,199 $ (1,170,574) $ 1,781,922 $ (15,732)